Search

everythinglearnresearchcommunity

for

Search:↓

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Finasteride increases CD8+ T cells in BPH tissues.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Finasteride improves hair loss in women with hyperandrogenism.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.